• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


CeQur Doubles Marlborough, Massachusetts, Operations Center

CeQur, a leader in simple insulin infusion for people with diabetes, is doubling the size of its production facilities in Marlborough, Massachusetts. The expansion is in preparation for the launch of its PAQ three-day insulin infusion device.

According to company officials, when completed later this year, the Marlborough facility will total 25,000 square feet, including a new clean room, labs and a manufacturing line. CeQur anticipates the expanded space will house 150 employees - the company's 50 current employees, in addition to more than 100 employees CeQur plans to hire over the next 24 months.

"Over the past year, we've optimized PAQ for high-volume, low-cost manufacturing and continued to amass clinical evidence that demonstrate PAQ will offer a safe, simple-to-use and cost-effective alternative to daily insulin injections for people with type 2 diabetes," said Doug Lawrence, CEO of CeQur. "We are excited to be expanding our facilities here in Marlborough in preparation for the market introduction of PAQ."

"Marlborough has been our U.S. base since CeQur was founded, and we've been extremely pleased with the resources available to us here, as well as the support we've received from the robust Massachusetts life-sciences and medical device community," said Lawrence. "We are confident that this is the best place to continue to build our company and capabilities."

"CeQur is a great example of the type of innovative company that helps make Massachusetts the global leader in life sciences," said Travis McCready, President/CEO of the MLSC. "The world's top 10 leading medical device companies all have a physical presence in Massachusetts, and we are pleased to see CeQur make a similar decision to invest, grow, and manufacture their products here. Their expansion will bring new jobs to Marlborough, further strengthening one of our state's fastest-growing life sciences hotspots. We look forward to being good partners with CeQur as they continue to grow in both scale and impact, improving care for people with diabetes."

"The continued investment and expansion of companies like CeQur speaks to Massachusetts' leadership in life sciences and the medical device industry," said Governor Charlie Baker. "The expansion of their facility in Marlborough and creation of new job opportunities is important not only to the people of the Commonwealth, but all those who can benefit from continued advancements in treatments for diabetes around the world."

Exclusive Research